Objective: To evaluate the usefulness of the combination of 99m Tc-sestamibi/ 99m Tc-pertechnetate subtraction scintigraphy (SS) and high-resolution neck ultrasonography (US) in patients with primary hyperparathyroidism (pHPT) undergoing parathyroidectomy. Design and Methods: Ninety-one patients with proved pHPT were studied, excluding patients with persistent or recurrent disease. There were 65 (71.4%) women and 26 (28.6%) men, with a median age of 59 years (range 18±78 years). All patients underwent both SS and US prior to surgery, and the results were compared with operative and histological findings. The intraoperative quick-parathyroid hormone assay was available for 52 (57.1%) patients. When multiglandular disease was found, both SS and US were considered truly positive only when at least two enlarged parathyroid (PT) glands had been localized. Results: Eighty-three (91.2%) solitary PT adenomas and three (3.3%) carcinomas were found. Moreover, two (2.2%) patients had a double adenoma and three (3.3%) patients had diffuse PT hyperplasia. The overall sensitivity of combined SS US was 94.5% (86.8% and 80.4% for SS and US respectively). There was a significant P , 0X05Y Student's t-test) difference in size between the PT glands correctly identified and undetected by SS, whereas the site of the removed PT tumors significantly P , 0X05Y Fisher exact test) influenced only the US sensitivity. Conclusions: When the preoperative localization of the PT glands is chosen, the combination of SS and US represents a reliable noninvasive localization technique and should be considered for use in each patient with pHPT undergoing surgery.
Introduction
The incidence of primary hyperparathyroidism (pHPT) is increasing and was estimated to be 42/100 000 per year, while in women over 60 years of age the average annual incidence rate approaches 190 cases/100 000 per year (1, 2) . Parathyroidectomy (PTx) should be considered in most symptomatic patients with confirmed pHPT, and bilateral neck exploration represents the standard initial surgical procedure since, in recent series, the overall reported cure rates may reach 95± 98% (3, 4) . Localization studies were often performed to simplify and shorten surgical exploration, but nevertheless a significant reduction in morbidity and duration of surgery was not reported in all studies and, for some surgeons, preoperative imaging of the parathyroid (PT) glands was unnecessary (5±8).
The aim of this study was to evaluate sensitivity and usefulness of high-resolution neck ultrasonography (US) and 99m Tc-sestamibi/ 99m Tc-pertechnetate subtraction scintigraphy (SS) as preoperative noninvasive localization procedures in patients with pHPT undergoing PTx.
Subjects and methods
Ninety-one consecutive patients (26 (28.6%) men and 65 (71.4%) women, median age 59 years, range 18± 78 years) with proved pHPT underwent both US and SS prior to successful PTx. Patients undergoing reexploration for recurrent or persistent pHPT were excluded. All patients were cured of hypercalcemia.
US was performed using 7.5-or 10-MHz real-time transducers and images were obtained from the angle of the mandible to the sternal notch. The sonographic appearance of an enlarged PT gland on grey-scale imaging was a hypoechoic nodule posterior or lateral to the thyroid lobe, but separate from it and nonadherent to surrounding tissues. SS was carried out using a single detector gamma camera with a parallel-hole high-resolution collimator interfaced to a computer. Patients were injected with 370 MBq 99m Tc-methoxyisobutylisonitrile (sestamibi) and 3 planar images (neck and mediastinum, anterior view, matrix 256 Â 256Y 300 s per view) were obtained 2±15 min later. Three more images were acquired after 150 MBq 99m Tc-pertechnetate administration. Image subtraction was obtained according to standard techniques and positive scan imaging was defined as a relative increased sestamibi uptake area persisting after images subtraction, as previously described (9) .
In any case, a successful bilateral neck exploration was performed and the excised PT glands were measured by the pathologist. Operative and histological findings were compared with the results of each localizing procedure. Intraoperative quick-parathyroid hormone (PTH) assay was available for 52 (57.1%) patients and the serum PTH levels were assayed prior to PT gland excision and 10±15 min after PTx.
The results were considered true-positive (TP) when the abnormal PT gland(s) found at operation had been correctly detected by the imaging techniques, falsepositive (FP) when US or SS did not show any diseased gland, and false-negative (FN) if no enlarged PT glands were localized. In patients with multiglandular disease both SS and US were considered TP only when at least two hyperfunctioning PT glands had been correctly identified. Sensitivity was defined as TPaTP FN and the positive predictive value (PPV) was defined as TPaTP FPX All reported data are expressed as means^standard deviation (S.D.) and comparisons between different groups were performed using twotailed Student's t-test and the Fisher exact test, when appropriate. The analysis of variance was also used, and in all cases, differences were considered significant at P , 0X05X
Results
In the overall population, the analysis of variance showed a significant F 125X82Y r 0X5359Y P 0X00 correlation between mean serum calcium 2X89^0X36 mmolal and intact-PTH 185X51 55X3 ngal levels. No difference P not significant (NS)) in age between male (M) and female (F) patients M 52X0^16X4; F 58X2^12X6 years) was found, whereas the mean serum calcium M 3X03^0X47; F 2X83^0X28 mmolal and PTH M 235X82 10X3; F 169X4^119X5 ngal values were significantly P , 0X05 lower in women.
Histopathological findings included 83 (91.2%) solitary adenomas, two (2.2%) double adenomas and three (3.3%) PT carcinomas; moreover, three (3.3%) patients had diffuse PT hyperplasia. The mean size (maximal diameter) of the removed PT glands was 19X32^9X41 mm median 17Y range 8±40 mm and they were in a typical site in 74 (81.3%) patients. Only in patients with solitary adenomas n 83 were the PT glands in an ectopic position n 17Y mainly in the upper mediastinum n 6 and behind the esophagus n 4 or the trachea n 4X In all patients n 52Y the intraoperative quick-PTH assay significantly (mean PTH values 150X80^27X83 compared with 19X70^6X65 ngal; P 0X00 fell after removal of the abnormal PT gland(s). Table 1 shows the sensitivity and PPV of SS and US. False positive results using US occurred in two patients with an ectopic PT adenoma and in two patients with multinodular goiter. SS was negative in 7/70 (10.0%) patients with TP US, and US was negative in 11/79 (13.9%) patients with TP SS.
In the group of patients with solitary tumors n 86Y the sensitivity of SS and US was 88.4% and 82.1% respectively. US correctly localized the PT adenomas in 7 out of the 10 patients with negative SS, thus the overall sensitivity of combined SS and US was 96.5%. In the patients with multiglandular disease n 5Y 16 enlarged typically located PT glands (4 adenomas and 12 hyperplastic PT glands) were found and subtotal PTx was performed in patients n 3 with diffuse hyperplasia. Both SS and US correctly localized the PT carcinomas n 3Y the double adenomas n 2Y two abnormal PT glands in one patient with PT hyperplasia and one enlarged gland in the others.
There was a significant P , 0X05 difference in the mean size of solitary PT adenomas n 83 correctly identified and undetected by SS ( Table 2 ). The site (typical or ectopic) of the removed abnormal PT glands did not affect P NS the results obtained by SS, but influenced P , 0X05 US sensitivity (Table 3) .
Discussion
In the 1980s, sensitivity for PT localization in patients with pHPT without previous surgery ranged between 35 and 74% (PT scintigraphy) and between 34 and 82% (US) (10) . The 1990 National Institutes of Health (NIH) Consensus Development Conference concluded that preoperative imaging was rarely indicated, had not proven to be cost-effective and did not shorten surgical (15, 21, 33) but none reported sensitivity of combined US SS in patients with pHPT. In our series, patients undergoing re-exploration were excluded, and the overall sensitivity of combined SS and US was 94.5%, whereas in those with single or double parathyroid tumors n 88 it was 96.6%. Moreover, SS sensitivity did significantly P , 0X05 correlate with the size of the PT adenoma, as previously observed (12, 13) but not with the site of the abnormal PT glands, and thus SS and US should be considered complementary.
Data from recent studies showed that more than 95% of PT adenomas may be correctly detected by 99m Tc-sestamibi scintigraphy (16, 20, 22) . Different techniques were used in performing PT scintigraphy, both with 99m Tc-sestamibi alone (12, 29, 30 ) and 99m Tc-sestamibi in conjunction with 123 I or 99m Tcpertechnetate for thyroid image subtraction (9, 26, 27) , with similar results. Dual phase imaging with single-photon emission computer tomography (SPECT) seems to be a promising procedure for the detection of hyperfunctioning PT tissue, both increasing the sensitivity of 99m Tc-sestamibi scintigraphy and appearing particularly useful in localizing mediastinal glands (38, 39) . In recent reports US sensitivity ranges between 76% and 91% and may improve using color and power Doppler sonography (36, 40) . Increased sensitivity using PTH assay in the needle aspirates of suspicious PT adenomas was also reported (41) .
Since the usefulness of localization procedures correlates with the number of preoperatively detected hyperfunctioning PT glands, sensitivity in patients with pHPT due to multiglandular disease may be lower, although it has also been suggested that SS can help distinguish hyperplasia from adenomatous disease (17) . However, in 85±90% of the patients pHPT is attributed to a single PT adenoma, even if a great variation exists in the reported incidence of multiglandular disease (42) . PT carcinoma is a rare tumor that in our experience was easy to detect preoperatively because of its relatively large size, usually ranging between 1.5 and 4.5 cm (43) .
Unilateral neck exploration and minimally invasive, radioguided or endoscopic surgery would be feasible if the site of the abnormal PT glands were known preoperatively. In this setting, the importance of noninvasive localizing procedures becomes evident (44±47). In any case, a careful bilateral neck exploration should be performed in the following situations: (i) no enlarged PT glands visualized, (ii) equivocal results of localizing procedures, (iii) SS and US not in agreement, or (iv) detection of two or more enlarged PT glands (33, 47) .
After excision of each abnormal PT gland, an intraoperative PTH assay represents the principal determinant of correction of the hyperparathyroid state and should be available for all patients with pHPT undergoing surgery (42, 48, 49) . In most studies, routine use of 99m Tc-sestamibi scintigraphy, neck ultrasonography and quick-PTH measurement was considered safe and cost-effective, significantly reducing operative time, facilitating successful limited neck exploration and improving the success rate of PTx, Table 3 Results obtained in patients with PT tumors localized in typical (n = 66) and ectopic (n = 17) sites using SS and US. Four patients (2 with ectopic parathyroid adenomas and 2 with tumors in typical site) had false positive results using US Site site of the PT adenomas; P values using Fisher's exact test).
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Site especially in patients with ectopic PT glands (9, 16, 34, 50±52) . Some authors estimated that US and PT scintigraphy charges accounted for only 2% and 5% respectively of the total charges for PTx, and that the added cost of protracted or failed exploration neutralized the costs of SS and US which are equivalent to 60 min operative time or less (13, 48, 53) . In spite of that some surgeons, on account of low sensitivity obtained with preoperative localization procedures in their experience, consider imaging of the PT glands unnecessary and recommend a careful bilateral neck exploration in all patients with pHPT (6, 8, 54) .
In conclusion, when a preoperative localization of the PT glands is chosen, the combination of SS and US represents a reliable noninvasive technique and should be considered for use in each patient undergoing surgery for pHPT. Tc-tetrofosmin and SPECT; (6) 99m Tcsestamibi/ 123 I subtraction scan; (7) 99m Tc-tetrofosmin/ 99m Tc-pertechnetate subtraction scan; TP true positive result; No. of PT glands number of parathyroid glands excised; nXrX not referred. 
